Kura Oncology, Inc.
KURA
$8.58
-$0.15-1.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -16.45% | 35.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.45% | 35.73% | |||
| Cost of Revenue | -5.07% | 8.16% | |||
| Gross Profit | 0.06% | 0.71% | |||
| SG&A Expenses | 19.18% | 30.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.84% | 14.55% | |||
| Operating Income | -7.84% | -10.09% | |||
| Income Before Tax | -9.19% | -12.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.29% | -12.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.29% | -12.09% | |||
| EBIT | -7.84% | -10.09% | |||
| EBITDA | -7.56% | -10.20% | |||
| EPS Basic | -8.79% | -12.01% | |||
| Normalized Basic EPS | -20.09% | -12.02% | |||
| EPS Diluted | -8.79% | -12.01% | |||
| Normalized Diluted EPS | -20.09% | -12.02% | |||
| Average Basic Shares Outstanding | 0.46% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.46% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||